Sky Century Investment, Inc.

FRC's fair value estimate for Sky Century Investment, Inc., and the rating behind it. SKYI last traded at $0.10; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Sky Century Investment, Inc.. Starting points for Sky Century Investment, Inc.: EPS -$0.02, beta -0.05 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Sky Century Investment, Inc.. Sky Century Investment, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Sky Century Investment, Inc.. Trailing twelve-month EPS for Sky Century Investment, Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Sky Century Investment, Inc.. Sky Century Investment, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Sky Century Investment, Inc. valued side by side against its closest peers. Sky Century Investment, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Sky Century Investment, Inc., and how their positions are changing. At a $223,725 market value, institutional positions materially move Sky Century Investment, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Sky Century Investment, Inc. executives and directors. Shares of Sky Century Investment, Inc. have traded between $0.0045 and $0.76 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Sky Century Investment, Inc.. Sky Century Investment, Inc. is a $223,725 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Sky Century Investment, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Sky Century Investment, Inc.. Coverage tracks Sky Century Investment, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.